288 related articles for article (PubMed ID: 32570122)
1. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
[TBL] [Abstract][Full Text] [Related]
2. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy and cardiovascular risk.
Gagliano-Jucá T; Basaria S
Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
[TBL] [Abstract][Full Text] [Related]
4. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
5. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Morrison BF; Reid M; Madden W; Burnett AL
Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
10. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
12. Risks of testosterone replacement therapy in ageing men.
Tan RS; Salazar JA
Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
14. Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men.
Blackwell K; Blackwell M; Blackwell T
Curr Cardiol Rep; 2023 Oct; 25(10):1157-1163. PubMed ID: 37733143
[TBL] [Abstract][Full Text] [Related]
15. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials.
Sood A; Hosseinpour A; Sood A; Avula S; Durrani J; Bhatia V; Gupta R
Endocr Pract; 2024 Jan; 30(1):2-10. PubMed ID: 37797887
[TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
[TBL] [Abstract][Full Text] [Related]
18. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
Khera M; Miner M; Jaffe J; Pastuszak AW
J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement therapy.
Barbonetti A; D'Andrea S; Francavilla S
Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy and cardiovascular events.
Çatakoğlu AB; Kendirci M
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
